- document
-
de Haas, M. (author), Thurik, F.F. (author), van der Ploeg, C.P.B. (author), Veldhuisen, B. (author), Hirschberg, H. (author), Soussan, A.A. (author), Woortmeijer, H. (author), Abbink, F. (author), Page-Christiaens, G.C.M.L. (author), Scheffer, P.G. (author), van der Schoot, C.E. (author)Objective To determine the accuracy of non-invasive fetal testing for the RHD gene in week 27 of pregnancy as part of an antenatal screening programme to restrict anti-D immunoglobulin use to women carrying a child positive for RHD. Design Prospectively monitoring of fetal RHD testing accuracy compared with serological cord blood typing on...article 2016
- document
- van der Schoot, C.E. (author), Thurik, F. (author), Scheffer, P.G. (author), Abbink, F. (author), van der Ploeg, C.P.B. (author), Veldhuisen, B. (author), de Haas, M. (author) conference paper 2013
- document
-
de Haas, M. (author), van der Ploeg, C.P.B. (author), Scheffer, P.G. (author), Verlinden, D.A. (author), Hirschberg, H. (author), Abbink, F. (author), van der Schoot, C.E. (author)In the Netherlands, since 1 July 2011, both antenatal anti-D immunoprophylaxis (1000 IU in the 30th week of gestation) and postnatal prophylaxis (1000 IU) is administered to only those women for whom a fetal RHD typing, performed in week 27 of pregnancy, predicts the presence of a D-positive child. The fetal RHD screening is part of the...article 2012